ARCHIVES

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

This article is from The Cancer Letter archive.

Vol. 11 No. 22 | May 31, 1985

Download PDF Visit The Full Archive

Related Articles

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Spring Meetings Will Concentrate Everyone In New Orleans – Except The Nurses

March 25, 1988

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

Hopkins Challenges Litton For Research Contract At FCRF

April 16, 1982

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013